Summary

Eligibility
for people ages 50-80 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UC Irvine
Dates
study started
study ends around
Principal Investigator
by Gelareh Sadigh, MD (uci)

Description

Summary

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Official Title

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)

Keywords

Lung Cancer, Lung Neoplasms, Patient education, Referral to financial navigation resources, Provider Reminers, Empower LCS

Eligibility

Locations

Lead Scientist at University of California Health

  • Gelareh Sadigh, MD (uci)
    Associate Professor, Radiological Sciences, School of Medicine. Authored (or co-authored) 132 research publications

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT06000683
Study Type
Interventional
Participants
About 70 people participating
Last Updated